Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
Type:
Grant
Filed:
August 29, 2019
Date of Patent:
May 11, 2021
Assignee:
PERGAMUM AB
Inventors:
Margit Mahlapuu, Mattias Munnich, Veronika Sjostrand
Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
Type:
Grant
Filed:
December 21, 2017
Date of Patent:
November 12, 2019
Assignee:
PERGAMUM AB
Inventors:
Margit Mahlapuu, Mattias Munnich, Veronika Sjostrand
Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
Type:
Grant
Filed:
August 13, 2014
Date of Patent:
January 30, 2018
Assignee:
PERGAMUM AB
Inventors:
Margit Mahlapuu, Mattias Münnich, Veronika Sjöstrand
Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
Type:
Grant
Filed:
January 25, 2012
Date of Patent:
September 15, 2015
Assignee:
Pergamum AB
Inventors:
Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
Type:
Grant
Filed:
January 25, 2012
Date of Patent:
September 30, 2014
Assignee:
Pergamum AB
Inventors:
Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours.
Type:
Application
Filed:
January 25, 2012
Publication date:
January 30, 2014
Applicant:
PERGAMUM AB
Inventors:
Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
Abstract: An antimicrobial peptide with heparin binding activity is described. It can be derived from endogenous mammalian proteins being substantially free from antimicrobial activity selected from the group consisting of laminin isoforms, complement factor C3, histidin rich glycoprotein and kininogen and having from 10 to 36 amino acids residues, wherein the antimicrobial peptide consists of at least four amino acid residues selected from the group consisting of K,R, and H. Also described are pharmaceutical compositions comprising said antimicrobial peptide and use of the antimicrobial peptide and/or antimicrobial/pharmaceutical composition.